AMR and Cancer - What Does the Future Look Like?

Antimicrobial resistance (AMR) is an increasingly important challenge in cancer care, influencing infection risk, treatment delivery, patient outcomes, and supportive care strategies across the oncology pathway. This three-part webinar series is designed for scientists and researchers with an interest in AMR who want to better understand the clinical realities, emerging evidence, and future challenges at the intersection of infection and cancer.

Bringing together experts in oncology, infectious diseases, immunology, and antimicrobial stewardship, the series will explore why cancer patients are uniquely vulnerable to resistant infections, how antimicrobials influence treatment outcomes, and what future models of stewardship could look like in oncology and palliative care settings.

The series is chaired by Prof Anna Olsson Brown and kindly supported by an education grant from bioMérieux. 

As part of the Microbiology Society's Knocking out AMR project, the Society presents 'What Does the Future Look Like?'. 
For this webinar, we have our chair Prof Anna Olsson-Brown and speakers:

Dr. Laura Ferreras, Consultant in Paediatric Infectious Diseases, Honorary Associate Professor at UCL Great Ormond Street Institute of Child Health

Orlagh McGarrity, Lead Antimicrobial Pharmacist Great Ormond Street Hospital for Children

Dr Jim Hatcher, Consultant in Microbiology and Virology and Lead AMS Microbiologist, Great Ormond Street Hospital for Children

The final webinar will focus on future directions and practical implementation. Discussions will consider how antimicrobial stewardship can be embedded into oncology and palliative care, the barriers to changing practice, and opportunities for integrating stewardship principles into patient-centred cancer care models.

This series offers a unique opportunity for AMR researchers to engage with clinicians and translational experts working at the frontline of cancer care, providing valuable clinical context for one of the most pressing interdisciplinary challenges in modern medicine.